UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Concordance of genomic alterations between primary and recurrent breast cancer

Molecular cancer therapeutics, 2014-05, Vol.13 (5), p.1382-1389

2014

Volltextzugriff (PDF)

Associations between Taste Perception Profiles and Empirically Derived Dietary Patterns: An Exploratory Analysis among Older Adults with Metabolic Syndrome

Nutrients, 2021-12, Vol.14 (1), p.142

2021

Volltextzugriff (PDF)

Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: A prospective study

Palliative medicine, 2014-04, Vol.28 (4), p.326-334

2014

Volltextzugriff (PDF)

AKT Inhibition in Solid Tumors With AKT1 Mutations

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2251-2259

2017

Volltextzugriff (PDF)

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

Journal of clinical oncology, 2018-11, Vol.36 (31), p.3134-3143

2018

Volltextzugriff (PDF)

MicroRNA profile in very young women with breast cancer

BMC cancer, 2014-07, Vol.14 (1), p.529-529, Article 529

2014

Volltextzugriff (PDF)

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer

Breast (Edinburgh), 2013-10, Vol.22 (5), p.974-979

2013

Volltextzugriff (PDF)

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

The New England journal of medicine, 2024-07, Vol.391 (1), p.44-55

2024

Volltextzugriff (PDF)

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Breast cancer research : BCR, 2019-09, Vol.21 (1), p.108-108, Article 108

2019

Volltextzugriff (PDF)

Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

European journal of cancer (1990), 2024-09, Vol.209, p.114270, Article 114270

2024

Volltextzugriff (PDF)

Abstract P3-13-01: Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-13-01

2015

Volltextzugriff (PDF)

Non-Hodgkin's Lymphoma in Older People: Age Is Not Always an Adverse Prognostic Factor

Journal of the American Geriatrics Society (JAGS), 2002-11, Vol.50 (11), p.1911-1912

2002

Volltextzugriff (PDF)

Pulmonary fibrosis induced by cyclophosphamide

The Annals of pharmacotherapy, 2001-07, Vol.35 (7-8), p.894-897

2001

Volltextzugriff (PDF)

Abstract CT331: “BEECH”, a phase I/II study of the AKT inhibitor AZD5363 combined with paclitaxel in patients with advanced or metastatic breast cancer: results from the dose-finding study, including quantitative assessment of circulating tumor DNA as a s

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.CT331-CT331

2015

Volltextzugriff (PDF)

Analysis of Clinical Prognostic Factors for Survival and Time to Progression in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil—Based Chemotherapy

Clinical colorectal cancer, 2003-02, Vol.2 (4), p.231-234

2003

Volltextzugriff (PDF)

Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer

Clinical & translational oncology, 2005-01, Vol.7 (1), p.23-28

2005

Volltextzugriff (PDF)

Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis

Anticancer research, 2024-03, Vol.44 (3), p.861-878

2024

Volltextzugriff (PDF)

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

The lancet oncology, 2018-06, Vol.19 (6), p.812-824

2018

Volltextzugriff (PDF)

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

The lancet oncology, 2022-08, Vol.23 (8), p.e374-e384

2022

Volltextzugriff (PDF)

Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations

Journal of clinical oncology, 2020-09, Vol.38 (26), p.3012-3023

2020

Volltextzugriff (PDF)

Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro

Pharmaceuticals (Basel, Switzerland), 2022-09, Vol.15 (9), p.1111

2022

Volltextzugriff (PDF)

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231157645-17588359231157645

2023

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(121)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(49)
Oncology
(46)
Female
(43)
Middle Aged
(27)
Aged
(26)
Adult
(22)
Tumors
(17)
Breast Cancer
(15)
Chemotherapy
(15)
Male
(15)
Cancer Therapies
(14)
Breast Neoplasms - Pathology
(11)
Neoplasm Staging
(11)
Patients
(11)
Breast Neoplasms - Drug Therapy
(10)
Ovarian Cancer
(10)
Aged, 80 And Over
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Concordance of genomic alterations between primary and recurrent breast cancer

Associations between Taste Perception Profiles and Empirically Derived Dietary Patterns: An Exploratory Analysis among Older Adults with Metabolic Syndrome

Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: A prospective study

AKT Inhibition in Solid Tumors With AKT1 Mutations

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

MicroRNA profile in very young women with breast cancer

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

Abstract P3-13-01: Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial

Non-Hodgkin's Lymphoma in Older People: Age Is Not Always an Adverse Prognostic Factor

Pulmonary fibrosis induced by cyclophosphamide

Abstract CT331: “BEECH”, a phase I/II study of the AKT inhibitor AZD5363 combined with paclitaxel in patients with advanced or metastatic breast cancer: results from the dose-finding study, including quantitative assessment of circulating tumor DNA as a s

Analysis of Clinical Prognostic Factors for Survival and Time to Progression in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil—Based Chemotherapy

Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer

Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations

Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)

Suchergebnisse filtern